Skip to content
2000
Volume 17, Issue 3
  • ISSN: 2589-9775
  • E-ISSN: 2589-9783

Abstract

Background

Neuropathic pain (NP) presents a significant actual public health challenge. Traditional treatments primarily involve medications, but these approaches frequently yield unsatisfactory results, highlighting the need to explore alternative therapies, such as platelet-rich plasma (PRP), an autologous plasma derivative enriched with platelets.

Objective

This article aims to systematically review the literature and provide an updated assessment of the efficacy and safety of PRP treatment for NP.

Methods

Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched databases, including Web of Science, Embase, PubMed, Scopus, and Cochrane Library. We assessed bias risk using the Cochrane Risk of Bias 2 tool (RoB2).

Results

Among 1230 studies identified, 12 randomized trials meeting eligibility criteria were included. Due to substantial heterogeneity, pairwise meta-analysis and intervention ranking were found to be unfeasible. Most trials suggest PRP is effective in relieving NP, with no reported serious complications or significant PRP-related adverse effects. However, these findings were compromised by methodological heterogeneity and study inconsistency.

Conclusion

PRP has shown to be promising as a safe therapeutic option for managing NP. Future studies should prioritize improved rigor and reproducibility for more stringent conclusions.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775321724240926114704
2024-10-10
2025-11-04

  • From This Site

    /content/journals/cdrr/10.2174/0125899775321724240926114704
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SmithB.H. HébertH.L. VeluchamyA. Neuropathic pain in the community: prevalence, impact, and risk factors.Pain2020161Suppl. 1S127S13710.1097/j.pain.000000000000182433090746
     [Google Scholar]
  2. DothA.H. HanssonP.T. JensenM.P. TaylorR.S. The burden of neuropathic pain: A systematic review and meta-analysis of health utilities.Pain2010149233834410.1016/j.pain.2010.02.03420227832
     [Google Scholar]
  3. SzewczykA. Jamroz-WiśniewskaA. HaratymN. RejdakK. Neuropathic pain and chronic pain as an underestimated interdisciplinary problem.Int. J. Occup. Med. Environ. Health202235324926410.13075/ijomeh.1896.0167635040826
     [Google Scholar]
  4. van HeckeO. AustinS.K. KhanR.A. SmithB.H. TorranceN. Neuropathic pain in the general population: A systematic review of epidemiological studies.Pain2014155465466210.1016/j.pain.2013.11.01324291734
     [Google Scholar]
  5. BouhassiraD. Lantéri-MinetM. AttalN. LaurentB. TouboulC. Prevalence of chronic pain with neuropathic characteristics in the general population.Pain2008136338038710.1016/j.pain.2007.08.01317888574
     [Google Scholar]
  6. BlancoE GalvezR ZamoranoE LópezV PérezM Prevalencia del dolor neuropathic (DN), según DN4, en attention primaria.SEMERGEN - Medicina de Familia2012382031010.1016/j.semerg.2011.10.012
     [Google Scholar]
  7. TorranceN. SmithB.H. BennettM.I. LeeA.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.J. Pain20067428128910.1016/j.jpain.2005.11.00816618472
     [Google Scholar]
  8. DielemanJ.P. KerklaanJ. HuygenF.J.P.M. BoumaP.A.D. SturkenboomM.C.J.M. Incidence rates and treatment of neuropathic pain conditions in the general population.Pain2008137368168810.1016/j.pain.2008.03.00218439759
     [Google Scholar]
  9. Mills SEE, MillsS.E.E. NicolsonK.P. SmithB.H. Chronic pain: A review of its epidemiology and associated factors in population-based studies.Br. J. Anaesth.20191232e273e28310.1016/j.bja.2019.03.02331079836
     [Google Scholar]
  10. IASP. Pain Terms. International Association for the Study of Pain.2012Available from: https://www.iasp-pain.org/resources/terminology/
  11. ScholzJ. FinnerupN.B. AttalN. AzizQ. BaronR. BennettM.I. BenolielR. CohenM. CruccuG. DavisK.D. EversS. FirstM. GiamberardinoM.A. HanssonP. KaasaS. KorwisiB. KosekE. Lavand’hommeP. NicholasM. NurmikkoT. PerrotS. RajaS.N. RiceA.S.C. RowbothamM.C. SchugS. SimpsonD.M. SmithB.H. SvenssonP. VlaeyenJ.W.S. WangS.J. BarkeA. RiefW. TreedeR.D. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.Pain20191601535910.1097/j.pain.000000000000136530586071
     [Google Scholar]
  12. AttalN. BouhassiraD. ColvinL. Advances and challenges in neuropathic pain: A narrative review and future directions.Br. J. Anaesth.20231311799210.1016/j.bja.2023.04.02137210279
     [Google Scholar]
  13. BarkeA. KorwisiB. JakobR. KonstanjsekN. RiefW. TreedeR.D. Classification of chronic pain for the International Classification of Diseases (ICD-11): results of the 2017 international World Health Organization field testing.Pain20221632e310e31810.1097/j.pain.000000000000228733863861
     [Google Scholar]
  14. BaskozosG. HébertH.L. PascalM.M.V. ThemistocleousA.C. MacfarlaneG.J. WynickD. BennettD.L.H. SmithB.H. Epidemiology of neuropathic pain: An analysis of prevalence and associated factors in UK Biobank.Pain Rep.202382e106610.1097/PR9.000000000000106637090682
     [Google Scholar]
  15. TreedeR.D. RiefW. BarkeA. AzizQ. BennettM.I. BenolielR. CohenM. EversS. FinnerupN.B. FirstM.B. GiamberardinoM.A. KaasaS. KorwisiB. KosekE. Lavand’hommeP. NicholasM. PerrotS. ScholzJ. SchugS. SmithB.H. SvenssonP. VlaeyenJ.W.S. WangS.J. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11).Pain20191601192710.1097/j.pain.000000000000138430586067
     [Google Scholar]
  16. SzokD. TajtiJ. NyáriA. VécseiL. TrojanoL. Therapeutic Approaches for Peripheral and Central Neuropathic Pain.Behav. Neurol.2019201911310.1155/2019/868595431871494
     [Google Scholar]
  17. BannisterK. SachauJ. BaronR. DickensonA.H. Neuropathic Pain: Mechanism-Based Therapeutics.Annu. Rev. Pharmacol. Toxicol.202060125727410.1146/annurev‑pharmtox‑010818‑02152431914896
     [Google Scholar]
  18. FinnerupN.B. KunerR. JensenT.S. Neuropathic Pain: From Mechanisms to Treatment.Physiol. Rev.2021101125930110.1152/physrev.00045.201932584191
     [Google Scholar]
  19. KufflerD.P. Mechanisms for Reducing Neuropathic Pain.Mol. Neurobiol.2020571678710.1007/s12035‑019‑01757‑931813127
     [Google Scholar]
  20. AttalN. Pharmacological treatments of neuropathic pain: The latest recommendations.Rev. Neurol. (Paris)20191751-2465010.1016/j.neurol.2018.08.00530318260
     [Google Scholar]
  21. CruccuG. TruiniA. A review of Neuropathic Pain: From Guidelines to Clinical Practice.Pain Ther.20176S1Suppl. 1354210.1007/s40122‑017‑0087‑029178033
     [Google Scholar]
  22. CollocaL. LudmanT. BouhassiraD. BaronR. DickensonA.H. YarnitskyD. FreemanR. TruiniA. AttalN. FinnerupN.B. EcclestonC. KalsoE. BennettD.L. DworkinR.H. RajaS.N. Neuropathic pain.Nat. Rev. Dis. Primers2017311700210.1038/nrdp.2017.228205574
     [Google Scholar]
  23. EisenbergE. SuzanE. Drug combinations in the treatment of neuropathic pain.Curr. Pain Headache Rep.2014181246310.1007/s11916‑014‑0463‑y25298046
     [Google Scholar]
  24. RosenbergerD.C. BlechschmidtV. TimmermanH. WolffA. TreedeR.D. Challenges of neuropathic pain: focus on diabetic neuropathy.J. Neural Transm. (Vienna)2020127458962410.1007/s00702‑020‑02145‑732036431
     [Google Scholar]
  25. PetroianuG.A. AloumL. AdemA. Neuropathic pain: Mechanisms and therapeutic strategies.Front. Cell Dev. Biol.202311107262910.3389/fcell.2023.107262936727110
     [Google Scholar]
  26. ThouayeM. YalcinI. Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons.Pharmacol. Ther.202325110854610.1016/j.pharmthera.2023.10854637832728
     [Google Scholar]
  27. GolzariS.E.J. SoleimanpourH. MahmoodpoorA. SafariS. AlaA. Lidocaine and pain management in the emergency department: A review article.Anesth. Pain Med.201433e1544410.5812/aapm.1544424660158
     [Google Scholar]
  28. GhojazadehM. SanaieS. ParsianZ. NajafizadehR. SoleimanpourH. Use of Lidocaine for Pain Management in the Emergency Medicine: A Systematic Review and Meta-Analysis.Ulum-i Daruyi201925317718310.15171/PS.2019.48
     [Google Scholar]
  29. SoleimanpourH. ImaniF. DolatiS. SoleimanpourM. ShahsavariniaK. Management of pain using magnesium sulphate: A narrative review.Postgrad. Med.2022134326026610.1080/00325481.2022.203509235086408
     [Google Scholar]
  30. Morteza BagiH. AhmadiS. TarighatF. RahbarghaziR. SoleimanpourH. Interplay between exosomes and autophagy machinery in pain management: State of the art.Neurobiol. Pain20221210009510.1016/j.ynpai.2022.10009535720640
     [Google Scholar]
  31. LatifiK. NegareshM. JavanshirN. SafariS. The Advent of Artificial Intelligence in Anesthesiology and Pain Management: A Review Article.International Journal of Drug Research in Clinics20231e1410.34172/ijdrc.2023.e14
     [Google Scholar]
  32. CavalliE. MammanaS. NicolettiF. BramantiP. MazzonE. The neuropathic pain: An overview of the current treatment and future therapeutic approaches.Int. J. Immunopathol. Pharmacol.20193310.1177/205873841983838330900486
     [Google Scholar]
  33. BuchheitT. HuhY. MaixnerW. ChengJ. JiR.R. Neuroimmune modulation of pain and regenerative pain medicine.J. Clin. Invest.202013052164217610.1172/JCI13443932250346
     [Google Scholar]
  34. AkedaK. YamadaJ. LinnE. SudoA. MasudaK. Platelet-rich plasma in the management of chronic low back pain: A critical review.J. Pain Res.20191275376710.2147/JPR.S15308530881089
     [Google Scholar]
  35. KnezevicN.N. CandidoK.D. DesaiR. KayeA.D. Is Platelet-Rich Plasma a Future Therapy in Pain Management?Med. Clin. North Am.2016100119921710.1016/j.mcna.2015.08.01426614728
     [Google Scholar]
  36. GrossenA.A. LeeB.J. ShiH.H. ShakirH.J. CornettE.M. KayeA.D. Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management.Curr. Pain Headache Rep.2022261074174910.1007/s11916‑022‑01082‑236087238
     [Google Scholar]
  37. MautnerK. MalangaG.A. SmithJ. ShipleB. IbrahimV. SampsonS. BowenJ.E. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature.PM R201574SSuppl.S53S5910.1016/j.pmrj.2015.02.00525864661
     [Google Scholar]
  38. BennellK.L. HunterD.J. PatersonK.L. Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis.Curr. Rheumatol. Rep.20171952410.1007/s11926‑017‑0652‑x28386761
     [Google Scholar]
  39. EvertsP. OnishiK. JayaramP. LanaJ.F. MautnerK. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.Int. J. Mol. Sci.20202120779410.3390/ijms2120779433096812
     [Google Scholar]
  40. TangJ.Z. NieM.J. ZhaoJ.Z. ZhangG.C. ZhangQ. WangB. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis.J. Orthop. Surg. Res.202015140310.1186/s13018‑020‑01919‑932912243
     [Google Scholar]
  41. MiglioriniF. DriessenA. QuackV. SippelN. CooperB. MansyY.E. TingartM. EschweilerJ. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: A Bayesian network meta-analysis.Arch. Orthop. Trauma Surg.202114191473149010.1007/s00402‑020‑03551‑y32725315
     [Google Scholar]
  42. FilardoG. PrevitaliD. NapoliF. CandrianC. ZaffagniniS. GrassiA. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.Cartilage2021131_suppl364S375S10.1177/194760352093117032551947
     [Google Scholar]
  43. LinH.W. TamK.W. LiouT.H. RauC.L. HuangS.W. HsuT.H. Efficacy of Platelet-Rich Plasma Injection on Range of Motion, Pain, and Disability in Patients With Adhesive Capsulitis: A Systematic Review and Meta-analysis.Arch. Phys. Med. Rehabil.2023104122109212210.1016/j.apmr.2023.03.03237119955
     [Google Scholar]
  44. ChenX.T. FangW. JonesI.A. HeckmannN.D. ParkC. VangsnessC.T.Jr The Efficacy of Platelet-Rich Plasma for Improving Pain and Function in Lateral Epicondylitis: A Systematic Review and Meta-analysis with Risk-of-Bias Assessment.Arthroscopy20213792937295210.1016/j.arthro.2021.04.06133964386
     [Google Scholar]
  45. BarmanA. SinhaM.K. SahooJ. JenaD. PatelV. PatelS. BhattacharjeeS. BaralD. Platelet-rich plasma injection in the treatment of patellar tendinopathy: A systematic review and meta-analysis.Knee Surg. Relat. Res.20223412210.1186/s43019‑022‑00151‑535509070
     [Google Scholar]
  46. JainD. GoyalT. VermaN. PaswanA.K. DubeyR.K. Intradiscal Platelet-Rich Plasma Injection for Discogenic Low Back Pain and Correlation with Platelet Concentration: A Prospective Clinical Trial.Pain Med.202021112719272510.1093/pm/pnaa25432869064
     [Google Scholar]
  47. Tuakli-WosornuY.A. TerryA. Boachie-AdjeiK. HarrisonJ.R. GribbinC.K. LaSalleE.E. NguyenJ.T. SolomonJ.L. LutzG.E. Lumbar Intradiskal Platelet‐Rich Plasma (PRP) Injections: A Prospective, Double‐Blind, Randomized Controlled Study.PM R20168111010.1016/j.pmrj.2015.08.01026314234
     [Google Scholar]
  48. WangS. LiuZ. WangJ. ChengL. HuJ. TangJ. Platelet-rich plasma (PRP) in nerve repair.Regen. Ther.20242724425010.1016/j.reth.2024.03.01738586873
     [Google Scholar]
  49. YuW. WangJ. YinJ. Platelet-rich plasma: A promising product for treatment of peripheral nerve regeneration after nerve injury.Int. J. Neurosci.2011121417618010.3109/00207454.2010.54443221244302
     [Google Scholar]
  50. BuntragulpoontaweeM. ChangK.V. VitoonpongT. PornjaksawanS. KitisakK. SaokaewS. KanchanasurakitS. The Effectiveness and Safety of Commonly Used Injectates for Ultrasound-Guided Hydrodissection Treatment of Peripheral Nerve Entrapment Syndromes: A Systematic Review.Front. Pharmacol.20211162115010.3389/fphar.2020.62115033746745
     [Google Scholar]
  51. DaveyM.S. DaveyM.G. HurleyE.T. CassidyJ.T. MullettH. McInerneyN.M. GalbraithJ.G. Platelet-rich plasma in non-operative management of mild to moderate carpal tunnel syndrome – A systematic review & meta-analysis of short-term outcomes.J. Orthop.20212515516110.1016/j.jor.2021.05.00435068775
     [Google Scholar]
  52. JiangJ. XingF. LuoR. LiuM. Effectiveness of Platelet-Rich Plasma for Patients With Carpal Tunnel Syndrome: A Systematic Review and meta-Analysis of Current Evidence in Randomized Controlled Trials.Front. Pharmacol.20221383421310.3389/fphar.2022.83421335571114
     [Google Scholar]
  53. GaoN. YanL. AiF. KangJ. WangL. WengY. Comparison of the Short-Term Clinical Effectiveness of 5% Dextrose Water, Platelet-rich Plasma and Corticosteroid Injections for Carpal Tunnel Syndrome: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.Arch. Phys. Med. Rehabil.2023104579981110.1016/j.apmr.2022.11.00936529261
     [Google Scholar]
  54. KliftoK.M. KliftoC.S. PidgeonT.S. RichardM.J. RuchD.S. ColbertS.H. Platelet-Rich Plasma versus Corticosteroid Injections for the Treatment of Mild-to-Moderate Carpal Tunnel Syndrome: A Markov Cost-Effectiveness Decision Analysis.Hand (N. Y.)202419111312710.1177/1558944722109205635603672
     [Google Scholar]
  55. HassanienM. ElawamyA. KamelE.Z. KhalifaW.A. AbolfadlG.M. RoushdyA.S.I. El ZohneR.A. MakaremY.S. Perineural platelet-rich plasma for diabetic neuropathic pain, could it make a difference?Pain Med.202021475776510.1093/pm/pnz14031298289
     [Google Scholar]
  56. SánchezM. AnituaE. DelgadoD. SanchezP. PradoR. OriveG. PadillaS. Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration.Expert Opin. Biol. Ther.201717219721210.1080/14712598.2017.125940927845852
     [Google Scholar]
  57. KimH.J. YeomJ.S. KohY.G. YeoJ.E. KangK.T. KangY.M. ChangB.S. LeeC.K. Anti‐inflammatory effect of platelet‐rich plasma on nucleus pulposus cells with response of TNF‐α and IL‐1.J. Orthop. Res.201432455155610.1002/jor.2253224338609
     [Google Scholar]
  58. PageM.J. McKenzieJ.E. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. MoherD. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.Int. J. Surg.20218810590610.1016/j.ijsu.2021.10590633789826
     [Google Scholar]
  59. HigginsJ. ThomasJ. ChandlerJ. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated march 2023).2023
     [Google Scholar]
  60. Faster Systematic Literature Reviews - Rayyan. (2023) Available from: https://rayyan.qcri.org/
  61. JensenT.S. BaronR. HaanpääM. KalsoE. LoeserJ.D. RiceA.S.C. TreedeR.D. A new definition of neuropathic pain.Pain2011152102204220510.1016/j.pain.2011.06.01721764514
     [Google Scholar]
  62. SterneJ.A.C. SavovićJ. PageM.J. ElbersR.G. BlencoweN.S. BoutronI. CatesC.J. ChengH.Y. CorbettM.S. EldridgeS.M. EmbersonJ.R. HernánM.A. HopewellS. HróbjartssonA. JunqueiraD.R. JüniP. KirkhamJ.J. LassersonT. LiT. McAleenanA. ReevesB.C. ShepperdS. ShrierI. StewartL.A. TillingK. WhiteI.R. WhitingP.F. HigginsJ.P.T. RoB 2: A revised tool for assessing risk of bias in randomised trials.BMJ2019366l489810.1136/bmj.l489831462531
     [Google Scholar]
  63. HashimN.A. FathyH.A. EsawyM.M. ShabanaM.A. Comparison of efficiency between platelet rich plasma and corticosteroid injection therapies in patients with Carpal tunnel syndrome: A prospective randomized controlled study.Egypt. J. Neurol. Psychiat. Neurosurg.20205615910.1186/s41983‑020‑00184‑1
     [Google Scholar]
  64. GadoS.E. EL-BannaH.S. Efficacy of platelet-rich plasma injection in mild and moderate carpal tunnel syndrome: randomized control study.Egypt. Rheumatol. Rehabil.2020471410.1186/s43166‑020‑00008‑3
     [Google Scholar]
  65. BozkurtM. TatarB.E. KarakolP. SezgiçM. UsluC. SolakH.T. GelbalC. Matriderm and platelet-rich plasma combination in the treatment of recurrent carpal tunnel syndrome: A new approach.Eur. J. Plast. Surg.202245229930610.1007/s00238‑021‑01863‑9
     [Google Scholar]
  66. SennaM.K. ShaatR.M. AliA.A.A. Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome.Clin. Rheumatol.201938123643365410.1007/s10067‑019‑04719‑731420812
     [Google Scholar]
  67. EltablM.A. SaifD.S. AlemamS.E. Platelet-rich plasma injection versus surgical and medical treatment of mild-moderate carpal tunnel syndrome.Egypt. J. Neurol. Psychiat. Neurosurg.20205618810.1186/s41983‑020‑00186‑z
     [Google Scholar]
  68. MalahiasM.A. NikolaouV.S. JohnsonE.O. KasetaM.K. KazasS.T. BabisG.C. Platelet‐rich plasma ultrasound‐guided injection in the treatment of carpal tunnel syndrome: A placebo‐controlled clinical study.J. Tissue Eng. Regen. Med.2018123e1480e148810.1002/term.256628873284
     [Google Scholar]
  69. RaeissadatS.A. KarimzadehA. HashemiM. BagherzadehL. Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial.BMC Musculoskelet. Disord.20181914910.1186/s12891‑018‑1963‑429433485
     [Google Scholar]
  70. WuY.T. HoT.Y. ChouY.C. KeM.J. LiT.Y. HuangG.S. ChenL.C. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial.Sci. Rep.2017719410.1038/s41598‑017‑00224‑628273894
     [Google Scholar]
  71. UzduA. KirazlıY. KarapolatH. UnluB. TanıgörG. ÇalışF.A. Efficacy of platelet-rich plasma in the treatment of hemiplegic shoulder pain.Neurol. Sci.20214251977198610.1007/s10072‑020‑04710‑032990858
     [Google Scholar]
  72. AnjayaniS Widodo WirohadidjojoY AdamAM SuwandiD SewengA Dali AmiruddinM Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma.Int J Dermatol.20145311091310.1111/ijd.12162
     [Google Scholar]
  73. XuZ. WuS. LiX. LiuC. FanS. MaC. Ultrasound-Guided Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar Disc Herniation: A Prospective, Randomized, Controlled Study.Neural Plast.2021202111110.1155/2021/555813834135954
     [Google Scholar]
  74. BaronR. BinderA. WasnerG. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.Lancet Neurol.20109880781910.1016/S1474‑4422(10)70143‑520650402
     [Google Scholar]
  75. BernatonieneJ. SciupokasA. KopustinskieneD.M. PetrikonisK. Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain.Pharmaceutics2023157179910.3390/pharmaceutics1507179937513986
     [Google Scholar]
  76. MoissetX. BouhassiraD. AttalN. French guidelines for neuropathic pain: An update and commentary.Rev. Neurol. (Paris)2021177783483710.1016/j.neurol.2021.07.00434332778
     [Google Scholar]
  77. FinnerupN.B. AttalN. HaroutounianS. McNicolE. BaronR. DworkinR.H. GilronI. HaanpääM. HanssonP. JensenT.S. KamermanP.R. LundK. MooreA. RajaS.N. RiceA.S.C. RowbothamM. SenaE. SiddallP. SmithB.H. WallaceM. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis.Lancet Neurol.201514216217310.1016/S1474‑4422(14)70251‑025575710
     [Google Scholar]
  78. XuanZ. YuW. DouY. WangT. Efficacy of Platelet-rich Plasma for Low Back Pain: A Systematic Review and Meta-analysis.J. Neurol. Surg. A Cent. Eur. Neurosurg.202081652953410.1055/s‑0040‑170917032438421
     [Google Scholar]
  79. BelkJ.W. KraeutlerM.J. HouckD.A. GoodrichJ.A. DragooJ.L. McCartyE.C. Platelet-Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Am. J. Sports Med.202149124926010.1177/036354652090939732302218
     [Google Scholar]
  80. FilardoG. Di MatteoB. KonE. MerliG. MarcacciM. Platelet-rich plasma in tendon-related disorders: results and indications.Knee Surg. Sports Traumatol. Arthrosc.20182671984199910.1007/s00167‑016‑4261‑427665095
     [Google Scholar]
  81. WippermanJ. GoerlK. Carpal Tunnel Syndrome: Diagnosis and Management.Am. Fam. Physician2016941299399928075090
     [Google Scholar]
  82. SarafA. HussainA. SandhuA.S. BishnoiS. AroraV. Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar radiculopathy: A Prospective, Double-Blind Randomized Study.Indian J. Orthop.20235771126113310.1007/s43465‑023‑00898‑337384009
     [Google Scholar]
  83. BiseS. DallaudiereB. PesquerL. PedramM. MeyerP. AntounM.B. HocqueletA. SilvestreA. Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain.Eur. Radiol.20203063152316010.1007/s00330‑020‑06733‑932095875
     [Google Scholar]
  84. LeV.T. Nguyen DaoL.T. NguyenA.M. Transforaminal injection of autologous platelet-rich plasma for lumbar disc herniation: A single-center prospective study in Vietnam.Asian J. Surg.202346143844310.1016/j.asjsur.2022.05.04735637114
     [Google Scholar]
  85. GuptaA. ChhabraH.S. SinghV. NagarjunaD. Lumbar Transforaminal Injection of Steroids versus Platelet-Rich Plasma for Prolapse Lumbar Intervertebral Disc with Radiculopathy: A Randomized Double-Blind Controlled Pilot Study.Asian Spine J.2024181586510.31616/asj.2023.011538433432
     [Google Scholar]
  86. CatapanoM. CatapanoJ. BorschelG. AlaviniaS.M. RobinsonL.R. MittalN. Effectiveness of Platelet-Rich Plasma Injections for Nonsurgical Management of Carpal Tunnel Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Arch. Phys. Med. Rehabil.2020101589790610.1016/j.apmr.2019.10.19331821797
     [Google Scholar]
  87. DongC. SunY. QiY. ZhuY. WeiH. WuD. LiC. Effect of Platelet-Rich Plasma Injection on Mild or Moderate Carpal Tunnel Syndrome: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.BioMed Res. Int.2020202011410.1155/2020/508937833274213
     [Google Scholar]
  88. PaduaL. CoraciD. ErraC. PazzagliaC. PaolassoI. LoretiC. CaliandroP. Hobson-WebbL.D. Carpal tunnel syndrome: clinical features, diagnosis, and management.Lancet Neurol.201615121273128410.1016/S1474‑4422(16)30231‑927751557
     [Google Scholar]
  89. WangL. Guiding Treatment for Carpal Tunnel Syndrome.Phys. Med. Rehabil. Clin. N. Am.201829475176010.1016/j.pmr.2018.06.00930293628
     [Google Scholar]
  90. KangH.J. JungS.H. YoonH.K. HahnS.B. KimS.J. Carpal tunnel syndrome caused by space occupying lesions.Yonsei Med. J.200950225726110.3349/ymj.2009.50.2.25719430560
     [Google Scholar]
  91. AllampallamK. ChakrabortyJ. RobinsonJ. Effect of ascorbic acid and growth factors on collagen metabolism of flexor retinaculum cells from individuals with and without carpal tunnel syndrome.J. Occup. Environ. Med.200042325125910.1097/00043764‑200003000‑0000510738704
     [Google Scholar]
  92. BohrenY. TimbolschiD.I. MullerA. BarrotM. YalcinI. SalvatE. Platelet‐rich plasma and cytokines in neuropathic pain: A narrative review and a clinical perspective.Eur. J. Pain2022261436010.1002/ejp.184634288258
     [Google Scholar]
  93. HirataH. NagakuraT. TsujiiM. MoritaA. FujisawaK. UchidaA. Effect of Ascorbic Acid and Growth Factors on Collagen Metabolism of Flexor Retinaculum Cells From Individuals With and Without Carpal Tunnel Syndrome.J. Pathol.200420460561210.1002/path.167315538733
     [Google Scholar]
  94. LanaJ.F.S.D. PuritaJ. PaulusC. HuberS.C. RodriguesB.L. RodriguesA.A. SantanaM.H. MadureiraJ.L.Jr LuzoÂ.C.M. BelangeroW.D. Annichino-BizzacchiJ.M. Contributions for classification of platelet rich plasma - Proposal of a new classification: MARSPILL.Regen. Med.201712556557410.2217/rme‑2017‑004228758836
     [Google Scholar]
  95. PachitoD.V. BagattiniÂ.M. de AlmeidaA.M. Mendrone-JúniorA. RieraR. Technical Procedures for Preparation and Administration of Platelet-Rich Plasma and Related Products: A Scoping Review.Front. Cell Dev. Biol.2020859881610.3389/fcell.2020.59881633363154
     [Google Scholar]
  96. LeA.D.K. EnwezeL. DeBaunM.R. DragooJ.L. Current Clinical Recommendations for Use of Platelet-Rich Plasma.Curr. Rev. Musculoskelet. Med.201811462463410.1007/s12178‑018‑9527‑730353479
     [Google Scholar]
  97. ChahlaJ. CinqueM.E. PiuzziN.S. MannavaS. GeeslinA.G. MurrayI.R. DornanG.J. MuschlerG.F. LaPradeR.F. A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting.J. Bone Joint Surg. Am.201799201769177910.2106/JBJS.16.0137429040132
     [Google Scholar]
  98. FadaduP.P. MazzolaA.J. HunterC.W. DavisT.T. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: A call for PRP standardization.Reg. Anesth. Pain Med.201944665265910.1136/rapm‑2018‑10035630992411
     [Google Scholar]
/content/journals/cdrr/10.2174/0125899775321724240926114704
Loading
Platelet-rich Plasma for the Treatment of Neuropathic Pain: A Systematic Review
Current Drug Research Reviews 17, 450 (2025); https://doi.org/10.2174/0125899775321724240926114704
/content/journals/cdrr/10.2174/0125899775321724240926114704
/content/journals/cdrr/10.2174/0125899775321724240926114704
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): analgesia; carpal tunnel syndrome; Neuropathic pain; platelet-rich plasma; systematic review; visual analog scale

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test